- Home
- GLMD vs SSKN Comparison
GLMD vs SSKN Comparison
Compare GLMD & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- SSKN
- Stock Information
- Founded
- GLMD 2000
- SSKN 1989
- Country
- GLMD Israel
- SSKN United States
- Employees
- GLMD N/A
- SSKN N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- SSKN Medical/Dental Instruments
- Sector
- GLMD Health Care
- SSKN Health Care
- Exchange
- GLMD Nasdaq
- SSKN Nasdaq
- Market Cap
- GLMD 7.5M
- SSKN 8.9M
- IPO Year
- GLMD 2014
- SSKN 2005
- Fundamental
- Price
- GLMD $1.51
- SSKN $1.57
- Analyst Decision
- GLMD Hold
- SSKN Strong Buy
- Analyst Count
- GLMD 1
- SSKN 1
- Target Price
- GLMD N/A
- SSKN $6.00
- AVG Volume (30 Days)
- GLMD 224.4K
- SSKN 2.9M
- Earning Date
- GLMD 08-28-2025
- SSKN 11-12-2025
- Dividend Yield
- GLMD N/A
- SSKN N/A
- EPS Growth
- GLMD N/A
- SSKN N/A
- EPS
- GLMD N/A
- SSKN N/A
- Revenue
- GLMD N/A
- SSKN $32,848,000.00
- Revenue This Year
- GLMD N/A
- SSKN N/A
- Revenue Next Year
- GLMD N/A
- SSKN $9.70
- P/E Ratio
- GLMD N/A
- SSKN N/A
- Revenue Growth
- GLMD N/A
- SSKN 0.36
- 52 Week Low
- GLMD $1.15
- SSKN $1.52
- 52 Week High
- GLMD $23.80
- SSKN $3.86
- Technical
- Relative Strength Index (RSI)
- GLMD 53.20
- SSKN 41.64
- Support Level
- GLMD $1.33
- SSKN $1.52
- Resistance Level
- GLMD $1.63
- SSKN $1.70
- Average True Range (ATR)
- GLMD 0.11
- SSKN 0.39
- MACD
- GLMD 0.03
- SSKN -0.04
- Stochastic Oscillator
- GLMD 69.23
- SSKN 2.14
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.